Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Riluzole
1.2.3 Edaravone
1.2.4 Glutamate Receptor Antagonist
1.2.5 Other
1.3 Market by Application
1.3.1 Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Amyotrophic Lateral Sclerosis
1.3.3 Spinal Muscular Atrophy
1.3.4 Multifocal Motor Neuropathy
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anterior Horn Cell Disease Treatment Market Perspective (2018-2029)
2.2 Global Anterior Horn Cell Disease Treatment Growth Trends by Region
2.2.1 Anterior Horn Cell Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Anterior Horn Cell Disease Treatment Historic Market Size by Region (2018-2024)
2.2.3 Anterior Horn Cell Disease Treatment Forecasted Market Size by Region (2024-2029)
2.3 Anterior Horn Cell Disease Treatment Market Dynamics
2.3.1 Anterior Horn Cell Disease Treatment Industry Trends
2.3.2 Anterior Horn Cell Disease Treatment Market Drivers
2.3.3 Anterior Horn Cell Disease Treatment Market Challenges
2.3.4 Anterior Horn Cell Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Anterior Horn Cell Disease Treatment by Players
3.1.1 Global Anterior Horn Cell Disease Treatment Revenue by Players (2018-2024)
3.1.2 Global Anterior Horn Cell Disease Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Anterior Horn Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Anterior Horn Cell Disease Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Anterior Horn Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Anterior Horn Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anterior Horn Cell Disease Treatment Revenue in 2022
3.5 Global Key Players of Anterior Horn Cell Disease Treatment Head office and Area Served
3.6 Global Key Players of Anterior Horn Cell Disease Treatment, Product and Application
3.7 Global Key Players of Anterior Horn Cell Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anterior Horn Cell Disease Treatment Breakdown Data by Type
4.1 Global Anterior Horn Cell Disease Treatment Historic Market Size by Type (2018-2024)
4.2 Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Type (2024-2029)
5 Anterior Horn Cell Disease Treatment Breakdown Data by Application
5.1 Global Anterior Horn Cell Disease Treatment Historic Market Size by Application (2018-2024)
5.2 Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Anterior Horn Cell Disease Treatment Market Size (2018-2029)
6.2 North America Anterior Horn Cell Disease Treatment Market Size by Type
6.2.1 North America Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024)
6.2.2 North America Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029)
6.2.3 North America Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
6.3 North America Anterior Horn Cell Disease Treatment Market Size by Application
6.3.1 North America Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024)
6.3.2 North America Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029)
6.3.3 North America Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
6.4 North America Anterior Horn Cell Disease Treatment Market Size by Country
6.4.1 North America Anterior Horn Cell Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
6.4.3 North America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Anterior Horn Cell Disease Treatment Market Size (2018-2029)
7.2 Europe Anterior Horn Cell Disease Treatment Market Size by Type
7.2.1 Europe Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024)
7.2.2 Europe Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029)
7.2.3 Europe Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
7.3 Europe Anterior Horn Cell Disease Treatment Market Size by Application
7.3.1 Europe Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024)
7.3.2 Europe Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029)
7.3.3 Europe Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
7.4 Europe Anterior Horn Cell Disease Treatment Market Size by Country
7.4.1 Europe Anterior Horn Cell Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
7.4.3 Europe Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Anterior Horn Cell Disease Treatment Market Size (2018-2029)
8.2 China Anterior Horn Cell Disease Treatment Market Size by Type
8.2.1 China Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024)
8.2.2 China Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029)
8.2.3 China Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
8.3 China Anterior Horn Cell Disease Treatment Market Size by Application
8.3.1 China Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024)
8.3.2 China Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029)
8.3.3 China Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Anterior Horn Cell Disease Treatment Market Size (2018-2029)
9.2 Asia Anterior Horn Cell Disease Treatment Market Size by Type
9.2.1 Asia Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024)
9.2.2 Asia Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029)
9.2.3 Asia Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
9.3 Asia Anterior Horn Cell Disease Treatment Market Size by Application
9.3.1 Asia Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024)
9.3.2 Asia Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029)
9.3.3 Asia Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
9.4 Asia Anterior Horn Cell Disease Treatment Market Size by Region
9.4.1 Asia Anterior Horn Cell Disease Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Anterior Horn Cell Disease Treatment Market Size by Region (2018-2024)
9.4.3 Asia Anterior Horn Cell Disease Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anterior Horn Cell Disease Treatment Introduction
11.1.4 Sanofi Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.1.5 Sanofi Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Anterior Horn Cell Disease Treatment Introduction
11.2.4 Novartis AG Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.2.5 Novartis AG Recent Developments
11.3 Mitsubishi Chemical Group Corporation
11.3.1 Mitsubishi Chemical Group Corporation Company Details
11.3.2 Mitsubishi Chemical Group Corporation Business Overview
11.3.3 Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Introduction
11.3.4 Mitsubishi Chemical Group Corporation Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.3.5 Mitsubishi Chemical Group Corporation Recent Developments
11.4 BrainStorm Cell Limited
11.4.1 BrainStorm Cell Limited Company Details
11.4.2 BrainStorm Cell Limited Business Overview
11.4.3 BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Introduction
11.4.4 BrainStorm Cell Limited Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.4.5 BrainStorm Cell Limited Recent Developments
11.5 Ionis Pharmaceuticals
11.5.1 Ionis Pharmaceuticals Company Details
11.5.2 Ionis Pharmaceuticals Business Overview
11.5.3 Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Introduction
11.5.4 Ionis Pharmaceuticals Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.5.5 Ionis Pharmaceuticals Recent Developments
11.6 Genervon Biopharmaceuticals, LLC
11.6.1 Genervon Biopharmaceuticals, LLC Company Details
11.6.2 Genervon Biopharmaceuticals, LLC Business Overview
11.6.3 Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Introduction
11.6.4 Genervon Biopharmaceuticals, LLC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.6.5 Genervon Biopharmaceuticals, LLC Recent Developments
11.7 Bausch Health Companies Inc
11.7.1 Bausch Health Companies Inc Company Details
11.7.2 Bausch Health Companies Inc Business Overview
11.7.3 Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Introduction
11.7.4 Bausch Health Companies Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.7.5 Bausch Health Companies Inc Recent Developments
11.8 F. Hoffmann-La Roche Ltd
11.8.1 F. Hoffmann-La Roche Ltd Company Details
11.8.2 F. Hoffmann-La Roche Ltd Business Overview
11.8.3 F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Introduction
11.8.4 F. Hoffmann-La Roche Ltd Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.8.5 F. Hoffmann-La Roche Ltd Recent Developments
11.9 Treeway B.V
11.9.1 Treeway B.V Company Details
11.9.2 Treeway B.V Business Overview
11.9.3 Treeway B.V Anterior Horn Cell Disease Treatment Introduction
11.9.4 Treeway B.V Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.9.5 Treeway B.V Recent Developments
11.10 CYTOKINETICS
11.10.1 CYTOKINETICS Company Details
11.10.2 CYTOKINETICS Business Overview
11.10.3 CYTOKINETICS Anterior Horn Cell Disease Treatment Introduction
11.10.4 CYTOKINETICS Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.10.5 CYTOKINETICS Recent Developments
11.11 AB Science
11.11.1 AB Science Company Details
11.11.2 AB Science Business Overview
11.11.3 AB Science Anterior Horn Cell Disease Treatment Introduction
11.11.4 AB Science Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.11.5 AB Science Recent Developments
11.12 ADVANZ PHARMA
11.12.1 ADVANZ PHARMA Company Details
11.12.2 ADVANZ PHARMA Business Overview
11.12.3 ADVANZ PHARMA Anterior Horn Cell Disease Treatment Introduction
11.12.4 ADVANZ PHARMA Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.12.5 ADVANZ PHARMA Recent Developments
11.13 Biogen
11.13.1 Biogen Company Details
11.13.2 Biogen Business Overview
11.13.3 Biogen Anterior Horn Cell Disease Treatment Introduction
11.13.4 Biogen Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.13.5 Biogen Recent Developments
11.14 Orphazyme
11.14.1 Orphazyme Company Details
11.14.2 Orphazyme Business Overview
11.14.3 Orphazyme Anterior Horn Cell Disease Treatment Introduction
11.14.4 Orphazyme Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.14.5 Orphazyme Recent Developments
11.15 KRIGLE PHARMA, INC
11.15.1 KRIGLE PHARMA, INC Company Details
11.15.2 KRIGLE PHARMA, INC Business Overview
11.15.3 KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Introduction
11.15.4 KRIGLE PHARMA, INC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.15.5 KRIGLE PHARMA, INC Recent Developments
11.16 Aquestive Therapeutics, Inc
11.16.1 Aquestive Therapeutics, Inc Company Details
11.16.2 Aquestive Therapeutics, Inc Business Overview
11.16.3 Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Introduction
11.16.4 Aquestive Therapeutics, Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.16.5 Aquestive Therapeutics, Inc Recent Developments
11.17 Apotex Inc
11.17.1 Apotex Inc Company Details
11.17.2 Apotex Inc Business Overview
11.17.3 Apotex Inc Anterior Horn Cell Disease Treatment Introduction
11.17.4 Apotex Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024)
11.17.5 Apotex Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Riluzole
Table 3. Key Players of Edaravone
Table 4. Key Players of Glutamate Receptor Antagonist
Table 5. Key Players of Other
Table 6. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Anterior Horn Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Anterior Horn Cell Disease Treatment Market Share by Region (2018-2024)
Table 10. Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Anterior Horn Cell Disease Treatment Market Share by Region (2024-2029)
Table 12. Anterior Horn Cell Disease Treatment Market Trends
Table 13. Anterior Horn Cell Disease Treatment Market Drivers
Table 14. Anterior Horn Cell Disease Treatment Market Challenges
Table 15. Anterior Horn Cell Disease Treatment Market Restraints
Table 16. Global Anterior Horn Cell Disease Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Anterior Horn Cell Disease Treatment Revenue Share by Players (2018-2024)
Table 18. Global Top Anterior Horn Cell Disease Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anterior Horn Cell Disease Treatment as of 2022)
Table 19. Global Anterior Horn Cell Disease Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Anterior Horn Cell Disease Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Anterior Horn Cell Disease Treatment, Headquarters and Area Served
Table 22. Global Key Players of Anterior Horn Cell Disease Treatment, Product and Application
Table 23. Global Key Players of Anterior Horn Cell Disease Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Anterior Horn Cell Disease Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Anterior Horn Cell Disease Treatment Revenue Share by Application (2018-2024)
Table 31. Global Anterior Horn Cell Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Anterior Horn Cell Disease Treatment Revenue Share by Application (2024-2029)
Table 33. North America Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Anterior Horn Cell Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Anterior Horn Cell Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Anterior Horn Cell Disease Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Anterior Horn Cell Disease Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Anterior Horn Cell Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 65. Sanofi Company Details
Table 66. Sanofi Business Overview
Table 67. Sanofi Anterior Horn Cell Disease Treatment Product
Table 68. Sanofi Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 69. Sanofi Recent Developments
Table 70. Novartis AG Company Details
Table 71. Novartis AG Business Overview
Table 72. Novartis AG Anterior Horn Cell Disease Treatment Product
Table 73. Novartis AG Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 74. Novartis AG Recent Developments
Table 75. Mitsubishi Chemical Group Corporation Company Details
Table 76. Mitsubishi Chemical Group Corporation Business Overview
Table 77. Mitsubishi Chemical Group Corporation Anterior Horn Cell Disease Treatment Product
Table 78. Mitsubishi Chemical Group Corporation Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 79. Mitsubishi Chemical Group Corporation Recent Developments
Table 80. BrainStorm Cell Limited Company Details
Table 81. BrainStorm Cell Limited Business Overview
Table 82. BrainStorm Cell Limited Anterior Horn Cell Disease Treatment Product
Table 83. BrainStorm Cell Limited Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 84. BrainStorm Cell Limited Recent Developments
Table 85. Ionis Pharmaceuticals Company Details
Table 86. Ionis Pharmaceuticals Business Overview
Table 87. Ionis Pharmaceuticals Anterior Horn Cell Disease Treatment Product
Table 88. Ionis Pharmaceuticals Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 89. Ionis Pharmaceuticals Recent Developments
Table 90. Genervon Biopharmaceuticals, LLC Company Details
Table 91. Genervon Biopharmaceuticals, LLC Business Overview
Table 92. Genervon Biopharmaceuticals, LLC Anterior Horn Cell Disease Treatment Product
Table 93. Genervon Biopharmaceuticals, LLC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 94. Genervon Biopharmaceuticals, LLC Recent Developments
Table 95. Bausch Health Companies Inc Company Details
Table 96. Bausch Health Companies Inc Business Overview
Table 97. Bausch Health Companies Inc Anterior Horn Cell Disease Treatment Product
Table 98. Bausch Health Companies Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 99. Bausch Health Companies Inc Recent Developments
Table 100. F. Hoffmann-La Roche Ltd Company Details
Table 101. F. Hoffmann-La Roche Ltd Business Overview
Table 102. F. Hoffmann-La Roche Ltd Anterior Horn Cell Disease Treatment Product
Table 103. F. Hoffmann-La Roche Ltd Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 104. F. Hoffmann-La Roche Ltd Recent Developments
Table 105. Treeway B.V Company Details
Table 106. Treeway B.V Business Overview
Table 107. Treeway B.V Anterior Horn Cell Disease Treatment Product
Table 108. Treeway B.V Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 109. Treeway B.V Recent Developments
Table 110. CYTOKINETICS Company Details
Table 111. CYTOKINETICS Business Overview
Table 112. CYTOKINETICS Anterior Horn Cell Disease Treatment Product
Table 113. CYTOKINETICS Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 114. CYTOKINETICS Recent Developments
Table 115. AB Science Company Details
Table 116. AB Science Business Overview
Table 117. AB Science Anterior Horn Cell Disease Treatment Product
Table 118. AB Science Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 119. AB Science Recent Developments
Table 120. ADVANZ PHARMA Company Details
Table 121. ADVANZ PHARMA Business Overview
Table 122. ADVANZ PHARMA Anterior Horn Cell Disease Treatment Product
Table 123. ADVANZ PHARMA Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 124. ADVANZ PHARMA Recent Developments
Table 125. Biogen Company Details
Table 126. Biogen Business Overview
Table 127. Biogen Anterior Horn Cell Disease Treatment Product
Table 128. Biogen Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 129. Biogen Recent Developments
Table 130. Orphazyme Company Details
Table 131. Orphazyme Business Overview
Table 132. Orphazyme Anterior Horn Cell Disease Treatment Product
Table 133. Orphazyme Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 134. Orphazyme Recent Developments
Table 135. KRIGLE PHARMA, INC Company Details
Table 136. KRIGLE PHARMA, INC Business Overview
Table 137. KRIGLE PHARMA, INC Anterior Horn Cell Disease Treatment Product
Table 138. KRIGLE PHARMA, INC Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 139. KRIGLE PHARMA, INC Recent Developments
Table 140. Aquestive Therapeutics, Inc Company Details
Table 141. Aquestive Therapeutics, Inc Business Overview
Table 142. Aquestive Therapeutics, Inc Anterior Horn Cell Disease Treatment Product
Table 143. Aquestive Therapeutics, Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 144. Aquestive Therapeutics, Inc Recent Developments
Table 145. Apotex Inc Company Details
Table 146. Apotex Inc Business Overview
Table 147. Apotex Inc Anterior Horn Cell Disease Treatment Product
Table 148. Apotex Inc Revenue in Anterior Horn Cell Disease Treatment Business (2018-2024) & (US$ Million)
Table 149. Apotex Inc Recent Developments
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Anterior Horn Cell Disease Treatment Market Share by Type: 2022 VS 2029
Figure 3. Riluzole Features
Figure 4. Edaravone Features
Figure 5. Glutamate Receptor Antagonist Features
Figure 6. Other Features
Figure 7. Global Anterior Horn Cell Disease Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Anterior Horn Cell Disease Treatment Market Share by Application: 2022 VS 2029
Figure 9. Amyotrophic Lateral Sclerosis Case Studies
Figure 10. Spinal Muscular Atrophy Case Studies
Figure 11. Multifocal Motor Neuropathy Case Studies
Figure 12. Other Case Studies
Figure 13. Anterior Horn Cell Disease Treatment Report Years Considered
Figure 14. Global Anterior Horn Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Anterior Horn Cell Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Anterior Horn Cell Disease Treatment Market Share by Region: 2022 VS 2029
Figure 17. Global Anterior Horn Cell Disease Treatment Market Share by Players in 2022
Figure 18. Global Top Anterior Horn Cell Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anterior Horn Cell Disease Treatment as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Anterior Horn Cell Disease Treatment Revenue in 2022
Figure 20. North America Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
Figure 22. North America Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
Figure 23. North America Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 24. United States Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Anterior Horn Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
Figure 28. Europe Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
Figure 29. Europe Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 30. Germany Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Anterior Horn Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
Figure 38. China Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
Figure 39. Asia Anterior Horn Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
Figure 41. Asia Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
Figure 42. Asia Anterior Horn Cell Disease Treatment Market Share by Region (2018-2029)
Figure 43. Japan Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Anterior Horn Cell Disease Treatment Market Share by Country (2018-2029)
Figure 53. Brazil Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Anterior Horn Cell Disease Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Sanofi Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 60. Novartis AG Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 61. Mitsubishi Chemical Group Corporation Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 62. BrainStorm Cell Limited Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 63. Ionis Pharmaceuticals Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 64. Genervon Biopharmaceuticals, LLC Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 65. Bausch Health Companies Inc Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 66. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 67. Treeway B.V Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 68. CYTOKINETICS Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 69. AB Science Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 70. ADVANZ PHARMA Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 71. Biogen Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 72. Orphazyme Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 73. KRIGLE PHARMA, INC Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 74. Aquestive Therapeutics, Inc Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 75. Apotex Inc Revenue Growth Rate in Anterior Horn Cell Disease Treatment Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed